These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 26800092)
41. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Chahin N; Engel AG Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720 [TBL] [Abstract][Full Text] [Related]
42. Update in inclusion body myositis. Machado P; Brady S; Hanna MG Curr Opin Rheumatol; 2013 Nov; 25(6):763-71. PubMed ID: 24067381 [TBL] [Abstract][Full Text] [Related]
45. Outcome measures in the idiopathic inflammatory myopathies: On the search for the holy grail. Dimachkie MM; Paganoni S Neurology; 2017 Jul; 89(1):20-21. PubMed ID: 28566551 [No Abstract] [Full Text] [Related]
46. Myopathies featuring non-caseating granulomas: Sarcoidosis, inclusion body myositis and an unfolding overlap. Alhammad RM; Liewluck T Neuromuscul Disord; 2019 Jan; 29(1):39-47. PubMed ID: 30578101 [TBL] [Abstract][Full Text] [Related]
47. Inclusion body myositis: clinical features and pathogenesis. Greenberg SA Nat Rev Rheumatol; 2019 May; 15(5):257-272. PubMed ID: 30837708 [TBL] [Abstract][Full Text] [Related]
48. Ongoing developments in sporadic inclusion body myositis. Machado PM; Ahmed M; Brady S; Gang Q; Healy E; Morrow JM; Wallace AC; Dewar L; Ramdharry G; Parton M; Holton JL; Houlden H; Greensmith L; Hanna MG Curr Rheumatol Rep; 2014 Dec; 16(12):477. PubMed ID: 25399751 [TBL] [Abstract][Full Text] [Related]
49. Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment. Needham M; Mastaglia FL Clin Neurophysiol; 2016 Mar; 127(3):1764-73. PubMed ID: 26778717 [TBL] [Abstract][Full Text] [Related]
50. Dysphagia as the Presenting Symptom for Inclusion Body Myositis. Esteban MJ; Kassar D; Padilla O; McCallum R J Investig Med High Impact Case Rep; 2021; 9():23247096211050211. PubMed ID: 34886694 [TBL] [Abstract][Full Text] [Related]
52. Inclusion-body myositis presenting with facial diplegia. Ghosh PS; Laughlin RS; Engel AG Muscle Nerve; 2014 Feb; 49(2):287-9. PubMed ID: 24038039 [TBL] [Abstract][Full Text] [Related]
53. Sporadic inclusion body myositis: new insights and potential therapy. Machado PM; Dimachkie MM; Barohn RJ Curr Opin Neurol; 2014 Oct; 27(5):591-8. PubMed ID: 25159931 [TBL] [Abstract][Full Text] [Related]
54. Inclusion Body Myositis and Neoplasia: A Narrative Review. Damian L; Login CC; Solomon C; Belizna C; Encica S; Urian L; Jurcut C; Stancu B; Vulturar R Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806366 [TBL] [Abstract][Full Text] [Related]
55. Possible future avenues for myositis therapeutics: DM, IMNM and IBM. Connolly CM; Plomp L; Paik JJ; Allenbach Y Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101762. PubMed ID: 35778272 [TBL] [Abstract][Full Text] [Related]
56. Exploring hand and upper limb function in patients with inclusion body myositis (IBM). Hunn S; Alfano L; Seiffert M; Weihl CC Neuromuscul Disord; 2023 Aug; 33(8):643-650. PubMed ID: 37451936 [TBL] [Abstract][Full Text] [Related]
59. Inclusion body myositis masquerading as cardiac dyspnea. Wan SH; Liang JJ; Greenlund AC J La State Med Soc; 2014; 166(6):254-7. PubMed ID: 25978663 [TBL] [Abstract][Full Text] [Related]
60. 272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands. Lilleker JB; Naddaf E; Saris CGJ; Schmidt J; de Visser M; Weihl CC; Neuromuscul Disord; 2024 Apr; 37():36-51. PubMed ID: 38522330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]